Location: Home
  • search
  • go
  • Relate News
  • 12/26/2022Two Large Out-licensing Deals Edge November Deal Values to Over $2.9B ...
  • 12/23/2022Eisai Initiates BLA Filing for Alzheimer's Drug Lecanemab in China
  • 12/22/2022Merck and Kelun Ink Exclusive License Pact for Seven Investigational ...
  • 12/22/2022NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
  • 12/22/2022NMPA and Chinese Customs Issues the Announcement for Regulation of Imp...
  • 12/22/2022CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs
  • 12/20/2022Chinese Pharmacopoeia Commission Publishes the Compilation Guidelines ...
  • 12/19/2022NMPA Hosts BRICS Drug Regulatory Authorities Meeting via Videoconferen...
  • 12/19/2022Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4...
  • 12/19/2022GenFleet and Merck Enter into Trial Collaboration to Initiate Study In...
  • 12/16/2022Recent Executive Moves
  • 12/15/2022Wuxi Biologics Removed from U.S. Unverified List
  • 12/14/2022Pfizer and China Meheco Announce Deal to Distribute COVID-19 Drug Paxl...
  • 12/14/2022Idorsia Out-licenses to Simcere Its Insomnia Drug Daridorexant in Chin...
  • 12/14/2022China Aims to Lead Next Bio Revolution with Investments in Advanced Bi...
  • 12/13/2022Biosion Enters Research Collaboration with ImmunoGen to Create Novel A...
  • 12/13/2022Financing Rebounds for Chinese Drugmakers in November
  • 12/12/2022IQVIA: Chinese Retail Pharmacy Sales down 3.6% in MAT Q3/2022
  • 12/12/2022Sinohealth: Drug Sales of Chinese Retail Pharmacy Sector Up 3.8% in Fi...
  • 12/8/2022Sinopharm Considering Bid to Take China TCM for $4B: Bloomberg
  • 12/8/2022November Sees Several Approvals for China-developed Drugs (PharmaDJ)
  • 12/6/2022NHSA Announces Postponement of On-Site Negotiations for the 2022 NRDL
  • 12/6/2022Summit and Akeso Reached ~$5B In-License Deal for Breakthru Innovative...
  • 12/5/2022Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...
  • 12/5/2022Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties: Asia ...
  • 12/2/2022HanAll's Licensed Partner in China Enters Sublicense Agreement with CS...
  • 12/2/2022Recent Executive Moves
  • 12/2/2022China's Challenge in the Drug Services Field (C&EN)
  • 12/1/2022A Growing Number of Drugmakers in China Are on A Quest to Treat NASH (...
  • 12/1/2022Eli Lilly Dumps Innovent's PD-1 after FDA Rebuff (FiercePharma)
  • Page:33/333 Total number of articles:9989: [First][<<] [31] [32] [33] [34] [35] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group